🔬 99%+ Purity Guaranteed·📋 COA on Every Order·🚚 Fast US Shipping·✅ Third-Party Lab Tested·🔒 Secure Checkout·🧬 12+ Premium Compounds·⚡ Same-Day Processing·🏆 Trusted by Athletes & Biohackers·🔬 99%+ Purity Guaranteed·📋 COA on Every Order·🚚 Fast US Shipping·✅ Third-Party Lab Tested·🔒 Secure Checkout·🧬 12+ Premium Compounds·⚡ Same-Day Processing·🏆 Trusted by Athletes & Biohackers·
Cagrilintide
MetabolicLab Use Only

Cagrilintide

Long-acting amylin analog studied for appetite control — potent in combination with GLP-1 agents.

Dosage
0.3–4.5 mg weekly subcutaneous injection
Half-life
~7 days
Purity
99%+
Form
Lyophilized powder
✅ 99%+ Purity📋 COA Included🚚 Fast US Shipping🔒 Secure Checkout

What Is Cagrilintide?

Cagrilintide is a long-acting analog of amylin — a pancreatic hormone co-secreted with insulin that plays a key role in regulating satiety and gastric emptying. It acts centrally to reduce appetite and food intake, and slows gastric emptying to extend feelings of fullness. In combination studies with GLP-1 receptor agonists (the CagriSema combination), it has demonstrated weight loss results substantially exceeding either agent alone, with up to 15–17% weight loss in Phase 3 trials.

Effectiveness Profile

Relative effectiveness scores derived from published preclinical literature across key endpoints.

Fat Loss88/100
Metabolic Health90/100
Insulin Sensitivity82/100
Appetite Control78/100

Scores are qualitative aggregates from animal and in vitro studies and are not a medical claim. For educational purposes only.

Applications & Benefits

Appetite suppression via amylin receptor pathway
Synergistic with GLP-1 agents for enhanced results
Slows gastric emptying for prolonged satiety
Metabolic health improvement
Lean muscle preservation during caloric restriction

Effect Timeline

Expected milestones based on published preclinical data.

1
Days 1–7
Receptor Activation

Metabolic receptor engagement begins. Early appetite modulation and glucose sensitivity improvements detectable.

2
Week 2–4
Metabolic Shift

Progressive improvements in glucose and insulin dynamics. Meaningful weight and fat reduction begins.

3
Week 4–8
Significant Changes

Visceral fat reduction measurable. Lipid profiles and metabolic markers show improvement.

4
Week 8–16
Sustained Optimization

Continued metabolic improvement. Insulin sensitivity stabilizes at improved baseline; weight loss sustained.

Timelines are derived from preclinical animal studies. Individual results in laboratory settings may vary. For educational purposes only.

Reconstitution Calculator

Calculate exact BAC water volume and dose measurements for Cagrilintide.

or custom:mg
250 mcg
50 mcg2000 mcg
Results
2500
mcg / mL
Concentration
0.10 mL
per injection
Draw Volume
20
injections
Total Doses

For laboratory use only. This calculator is a reference tool — verify all calculations before use. Always use sterile technique with bacteriostatic water and sterile syringes.

Related Topics

metabolicweight lossamylinappetitesatietyinsulin
🧬

Cagrilintide

For educational use only · Verified vendor

Dosage0.3–4.5 mg weekly subcutaneous injection
Half-life~7 days
FormLyophilized powder
Purity99%+
CategoryMetabolic
Buy NowCompare with other peptides →

Quality Assurance

🔬Third-Party Lab Tested
📋COA Available on Request
99%+ Purity Verified
🚚Fast US Shipping
🔒Secure Checkout
❄️Cold-Chain Handled
Buy Now →